Document:

<PAGE>

                                                                  EXHIBIT 10.15

                           CLEARCOMMERCE CORPORATION

                        COMMON STOCK PURCHASE AGREEMENT

                                 MARCH 6, 2000
<PAGE>

                               TABLE OF CONTENTS
                                                                            Page
                                                                            ----

1.   Purchase and Sale of Stock............................................... 1

     1.1   Sale and Issuance of Common Stock.................................. 1
     1.2   Closing; Closing Dates; Delivery................................... 1

2.   Representations and Warranties of the Company............................ 1

     2.1   Organization, Good Standing and Qualification...................... 2
     2.2   Capitalization and Voting Rights................................... 2
     2.3   Subsidiaries....................................................... 3
     2.4   Authorization...................................................... 3
     2.5   Valid Issuance of Common Stock..................................... 3
     2.6   Governmental Consents.............................................. 3
     2.7   Offering........................................................... 4
     2.8   Litigation......................................................... 4
     2.9   Employee Agreements................................................ 4
     2.10  Patents and Trademarks............................................. 4
     2.11  Compliance with Other Instruments.................................. 5
     2.12  Agreements; Action................................................. 5
     2.13  Related-Party Transactions......................................... 6
     2.14  Permits............................................................ 6
     2.15  Environmental and Safety Laws...................................... 7
     2.16  Disclosure......................................................... 7
     2.17  Registration Rights................................................ 7
     2.18  Corporate Documents................................................ 7
     2.19  Title to Property and Assets....................................... 7
     2.20  Financial Statements............................................... 7
     2.21  Changes............................................................ 8
     2.22  Tax Returns, Payments and Elections................................ 8
     2.23  Insurance.......................................................... 8
     2.24  Minute Books....................................................... 8
     2.25  Employee Matters................................................... 8
     2.26  Brokers............................................................ 9

3.   Representations and Warranties of the Investors.......................... 9

     3.1   Authorization...................................................... 9
     3.2   Purchase Entirely for Own Account.................................. 9
     3.3   Disclosure of Information.......................................... 9
     3.4   Investment Experience.............................................. 9
     3.5   Accredited Investor................................................10
     3.6   Restricted Securities..............................................10
     3.7   Further Limitations on Disposition.................................10
     3.8   Legends............................................................11

4.   Conditions of Investors' Obligations at Closing..........................11

                                      -i-
<PAGE>

                               TABLE OF CONTENTS
                                  (continued)
                                                                            Page
                                                                            ----

     4.1   Representations and Warranties.....................................11
     4.2   Performance........................................................11
     4.3   Compliance Certificate.............................................11
     4.4   Qualifications.....................................................12
     4.5   Proceedings and Documents..........................................12
     4.6   Investor Rights Agreement..........................................12

5.   Conditions of the Company's Obligations at Closing.......................12

     5.1   Representations and Warranties.....................................12
     5.2   Payment of Purchase Price..........................................12
     5.3   Qualifications.....................................................12
     5.4   Lockup.............................................................13

6.   Post-Closing Covenants...................................................13

     6.1   Use of Proceeds....................................................13

7.   Miscellaneous............................................................13

     7.1   Survival of Warranties.............................................13
     7.2   Successors and Assigns.............................................13
     7.3   Governing Law......................................................13
     7.4   Counterparts.......................................................13
     7.5   Titles and Subtitles...............................................13
     7.6   Notices............................................................14
     7.7   Finder's Fee.......................................................14
     7.8   Expenses...........................................................14
     7.9   Amendments and Waivers.............................................14
     7.10  Severability.......................................................14
     7.11  Aggregation of Stock...............................................15
     7.12  Entire Agreement...................................................15

EXHIBIT A  -   Schedule of Investors
EXHIBIT B  -   Schedule of Exceptions
EXHIBIT C  -   Addendum to Investor Rights Agreement
EXHIBIT D  -   Lockup Agreement

                                      -ii-
<PAGE>

                           CLEARCOMMERCE CORPORATION

                        COMMON STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE AGREEMENT is made as of March 6, 2000, by and among
ClearCommerce Corporation, a Delaware corporation (the "Company"), and the
investors, severally and not jointly, listed on Exhibit A hereto, each of which
                                                ---------
is herein referred to as an "Investor."

     THE PARTIES HEREBY AGREE AS FOLLOWS:

1.   Purchase and Sale of Stock.
     --------------------------

     1.1  Sale and Issuance of Common Stock.
          ---------------------------------

          (a)  On or prior to the Closing, the Company shall have authorized the
sale and issuance to the Investors of the Common Stock (the "Securities").

          (b) Subject to the terms and conditions of this Agreement, each
Investor agrees, severally and not jointly, to purchase at the Closing and the
Company agrees to sell and issue to each Investor at the Closing, that number of
shares of the Company's Common Stock set forth opposite such Investor's name on
Exhibit A hereto for the IPO Price as defined in Exhibit A.
---------                                        ---------

     1.2  Closing; Closing Dates; Delivery.
          --------------------------------

          (a)  Closing.  The closing of the purchase and sale of the Common
               -------
Stock (the "Closing") and shall take place at the offices of Wilson Sonsini
Goodrich & Rosati, Professional Corporation, 8911 Capital of Texas Highway,
Suite 3350, Austin, Texas. The Closing will take place at 8:00 a.m. central time
on the date of the closing of a Qualified IPO (as defined below); provided that
the Closing may occur at such other time and place as the Company and Investors
acquiring in the aggregate more than half the shares of Common Stock sold
pursuant hereto mutually agree upon orally or in writing. If the Closing has not
occurred on or prior to September 1, 2000, this Agreement shall terminate and
the parties hereto shall be free from their respective obligations hereunder.

          (b)  Delivery.  At each Closing, the Company shall deliver to each
               --------
Investor a certificate representing the Common Stock that such Investor is
purchasing against payment of the purchase price therefor by check, wire
transfer, cancellation of indebtedness, or any combination thereof.

2.   Representations and Warranties of the Company.
     ---------------------------------------------

     The Company hereby represents and warrants to each Investor that, except as
set forth on Exhibit B (the "Schedule of Exceptions") furnished to each
             ---------
Investor, specifically identifying the relevant subparagraph hereof, which
exceptions shall be deemed to be representations and warranties as if made
hereunder:
<PAGE>

     2.1  Organization, Good Standing and Qualification.
          ---------------------------------------------

     The Company is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware and has all requisite corporate
power and authority to carry on its business as now conducted and as proposed to
be conducted.  The Company is duly qualified to transact business and is in good
standing in each jurisdiction in which the failure to so qualify would have a
material adverse effect on its business or properties.

     2.2  Capitalization and Voting Rights.
          --------------------------------

          (a)  At the Closing, the authorized capital of the Company will
consist of:

               (i)  Preferred Stock.  12,647,830 shares of preferred stock,
                    ---------------
par value $0.001 (the "Preferred Stock"), of which (i) three million one hundred
forty-seven thousand eight hundred thirty (3,147,830) shares have been
designated Series A Preferred Stock (the "Series A Preferred Stock"), all of
which shares of Series A Preferred Stock are issued and outstanding; (ii) four
million nine hundred thousand (4,900,000) shares have been designated Series B
Preferred Stock (the "Series B Preferred Stock"), of which four million seven
hundred six thousand one hundred ninety-six (4,706,196) shares are outstanding;
and (iii) 4,600,000 shares have been designated Series C Preferred Stock, four
million two hundred forty three thousand two hundred sixty-seven (4,243,267) of
which are outstanding prior to the Closing.

               (ii) Common Stock.  20,000,000 shares of common stock, par
                    ------------
value $0.001 ("Common Stock"), of which 3,925,762 shares are issued and
outstanding.

          (b)  INTENTIONALLY OMITTED.

          (c)  The outstanding shares of Series A Preferred Stock, Series B
Preferred Stock and Common Stock are all duly and validly authorized and issued,
fully paid and nonassessable, and were issued in accordance with the
registration or qualification provisions of the Securities Act of 1933, as
amended (the "Act") and any relevant state securities laws, or pursuant to valid
exemptions therefrom.

          (d)  Except for (A) the conversion privileges of the Series A
Preferred Stock, the Series B Preferred Stock and Series C Preferred Stock, (B)
the rights provided in Section 3.4 of that certain Third Amended and Restated
Investors' Rights Agreement dated December 31, 1999 (the "Investor Rights
Agreement"), (C) currently outstanding warrants to purchase six hundred eighty
thousand one hundred eighty-three (680,183) shares of Common Stock, (D)
currently outstanding or committed options to purchase one million two hundred
ninety-eight thousand nine hundred fourteen (1,298,914) shares of Common Stock
granted to employees and other service providers pursuant to the Company's 1997
Stock Option Plan (the "Option Plan"), (E) currently outstanding warrants to
purchase one hundred thirty thousand two hundred thirty-five (130,235) shares of
the Company's Series B Preferred Stock, and (F) the rights granted under the
Addendum to Third Amended and Restated Investors' Rights Agreement (the
"Addendum"), there are

                                      -2-
<PAGE>

not outstanding any options, warrants, rights (including conversion or
preemptive rights) or agreements for the purchase or acquisition from the
Company of any shares of its capital stock. In addition to the aforementioned
options, the Company has reserved an additional 1,347,964 shares of its Common
Stock for purchase upon exercise of options to be granted in the future under
the Option Plan. Other than as set forth in Section 3.6 of the Investor Rights
Agreement, the Company is not a party or subject to any agreement or
understanding, and, to the Company's knowledge, there is no agreement or
understanding between any persons and/or entities, which affects or relates to
the voting or giving of written consents with respect to any security or by a
director of the Company.

     2.3  Subsidiaries.
          ------------

     The Company does not presently own or control, directly or indirectly, any
interest in any other corporation, association, or other business entity.  The
Company is not a participant in any joint venture, partnership, or similar
arrangement.

     2.4  Authorization.
          -------------

     All corporate action on the part of the Company, its officers, directors
and stockholders necessary for the authorization, execution and delivery of this
Agreement and the Addendum, the performance of all obligations of the Company
hereunder and thereunder, and the authorization, issuance, sale and delivery of
the Common Stock being sold hereunder has been taken or will be taken prior to
the Closing, and this Agreement and the Addendum, constitute valid and legally
binding obligations of the Company, enforceable in accordance with their
respective terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, and other laws of general application affecting
enforcement of creditors' rights generally, and (ii) as limited by laws relating
to the availability of specific performance, injunctive relief, or other
equitable remedies

     2.5  Valid Issuance of Common Stock.
          ------------------------------

     The Common Stock that is being purchased by the Investors hereunder, when
issued, sold and delivered in accordance with the terms of this Agreement for
the consideration expressed herein, will be duly and validly issued, fully paid,
and nonassessable, and will be free of restrictions on transfer other than
restrictions on transfer under this Agreement, the Lockup Agreement (as defined
below) and the Investor Rights Agreement and under applicable state and federal
securities laws.

     2.6  Governmental Consents.
          ---------------------

     Other than filings which are required pursuant to federal or state
securities laws, no consent, approval, order or authorization of, or
registration, qualification, designation, declaration or filing with, any
federal, state or local governmental authority on the part of the Company is
required in connection with the consummation of the transactions contemplated by
this Agreement.

                                      -3-
<PAGE>

     2.7  Offering.
          --------

     Subject in part to the truth and accuracy of each Investor's
representations set forth in Section 3 of this Agreement, the offer, sale and
issuance of the Common Stock as contemplated by this Agreement are exempt from
the registration requirements of the Act, and neither the Company nor any
authorized agent acting on its behalf will take any action hereafter that would
cause the loss of such exemption.

     2.8  Litigation.
          ----------

     There is no material action, suit, proceeding or investigation pending or,
to the Company's knowledge, threatened against the Company that questions the
validity of this Agreement, or the Addendum or the right of the Company to enter
into such agreements, or to consummate the transactions contemplated hereby, or
that might result, either individually or in the aggregate, in any material
adverse changes in the assets, condition, affairs or prospects of the Company,
financially or otherwise, or any change in the current equity ownership of the
Company, nor is the Company aware that there is any basis for the foregoing. The
foregoing includes, without limitation, actions, suits, proceedings or
investigations pending or threatened (or any basis therefor known to the
Company) involving (a) the prior employment of any of the Company's employees,
their use in connection with the Company's business of any information or
techniques allegedly proprietary to any of their former employers, or their
obligations under any agreements with prior employers or (b) negotiations by the
Company with potential investors in the Company. The Company is not a party or
subject to the provisions of any order, writ, injunction, judgment or decree of
any court or government agency or instrumentality. There is no action, suit,
proceeding or material investigation by the Company currently pending or that
the Company intends to initiate.

     2.9  Employee Agreements.
          -------------------

     Each employee, officer and consultant of the Company has executed a
Proprietary Information and Invention Assignment Agreement.  The Company is not
aware that any of its employees, officers or consultants is in violation thereof
that could reasonably be expected to have a material adverse effect on the
Company.

     2.10 Patents and Trademarks.
          ----------------------

     The Company has sufficient title, right to use and ownership of all
patents, trademarks, service marks, trade names, copyrights, trade secrets,
information, proprietary rights and processes necessary for its business as now
conducted and as presently proposed to be conducted, to the Company's knowledge,
without any conflict with or infringement of the rights of others.  The Schedule
of Exceptions contains a complete list of patents and pending patent
applications of the Company.  Except for licenses of "prepackaged" software, and
licenses of the Company's software in the ordinary course of business (those of
which that are material are listed on the Schedule of Exceptions), there are no
outstanding options, licenses, or agreements of any kind relating to the
foregoing, nor is the Company bound by or a party to any options, licenses or
agreements of any kind with respect to the patents, trademarks, service marks,
trade names, copyrights, trade secrets,

                                      -4-
<PAGE>

licenses, information, proprietary rights and processes of any other person or
entity. The Company has not received any communications alleging that the
Company has violated or, by conducting its business as currently proposed, would
violate any of the patents, trademarks, service marks, trade names, copyrights
or trade secrets or other proprietary rights of any other person or entity. The
Company is not aware that any of its employees is obligated under any contract
(including licenses, covenants or commitments of any nature) or other agreement,
or subject to any judgment, decree or order of any court or administrative
agency, that would interfere with the use of his or her best efforts to promote
the interests of the Company or that would conflict with the Company's business
as currently proposed to be conducted. Neither the execution nor delivery of
this Agreement, nor the carrying on of the Company's business by the employees
of the Company, will, to the Company's knowledge, conflict with or result in a
breach of the terms, conditions or provisions of, or constitute a default under,
any contract, covenant or instrument under which any of such employees is now
obligated. The Company does not believe it is or will be necessary in the
conduct of its business to utilize any inventions of any of its employees made
prior to their employment by the Company.

     2.11 Compliance with Other Instruments.
          ---------------------------------

     The Company is not in violation or default of any provision of its
Certificate of Incorporation, as amended, or Bylaws, or of any instrument or
contract to which it is a party or by which it is bound, or, to its knowledge,
of any provision of any judgment, order, writ or decree or any federal or state
statute, rule or regulation applicable to the Company. The execution, delivery
and performance of this Agreement and the Addendum, and the consummation of the
transactions contemplated hereby and thereby will not result in any such
violation or be in conflict with or constitute, with or without the passage of
time and giving of notice, either a material default under any such provision,
instrument, judgment, order, writ, decree or contract or an event that results
in the creation of any lien, charge or encumbrance upon any assets of the
Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of
any material permit, license, authorization, or approval applicable to the
Company, its business or operations or any of its assets or properties.

     2.12 Agreements; Action
          ------------------

     Except for agreements explicitly contemplated hereby, since December 31,
1999:

          (a)  There are no agreements, understandings or proposed transactions
between the Company and any of its officers, directors, stockholders,
affiliates, or any affiliate thereof.

          (b)  Other than contracts entered into in the ordinary course of
business, there are no agreements, understandings, instruments, contracts,
proposed transactions, or, to its knowledge, judgments, orders, writs or
decrees, to which the Company is a party or by which it is bound that may
involve (i) obligations (contingent or otherwise) of, or payments to the Company
in excess of, $25,000, or (ii) the license of any patent, copyright, trade
secret or other proprietary right to or from the Company, or (iii) provisions
restricting or affecting the development, manufacture or distribution of the
Company's products or services, or (iv) indemnification by the Company with
respect to infringements of proprietary rights.

                                      -5-
<PAGE>

          (c)  The Company has not (i) declared or paid any dividends or
authorized or made any distribution upon or with respect to any class or Series
of its capital stock, (ii) incurred any indebtedness for money borrowed or any
other liabilities individually in excess of $10,000 or, in the case of
indebtedness and/or liabilities individually less than $10,000, in excess of
$50,000 in the aggregate, (iii) made any loans or advances to any person, other
than ordinary advances for travel expenses, or (iv) sold, exchanged or otherwise
disposed of any of its assets or rights, other than the sale of its inventory in
the ordinary course of business.

          (d)  For the purposes of subsections (b) and (c) above, all
indebtedness, liabilities, agreements, understandings, instruments, contracts
and proposed transactions involving the same person or entity (including persons
or entities the Company has reason to believe are affiliated therewith) shall be
aggregated for the purpose of meeting the individual minimum dollar amounts of
such subsections.

          (e)  The Company is not a party to and is not bound by any contract,
agreement or instrument, or subject to any restriction under its Amended
Certificate or Bylaws that materially adversely affects its business as now
conducted or as currently proposed to be conducted, its properties or its
financial condition.

     2.13 Related-Party Transactions.
          --------------------------

     No employee, officer, director or stockholder of the Company or member of
his or her immediate family is indebted to the Company, nor is the Company
indebted (or committed to make loans or extend or guarantee credit) to any of
them.  To the Company's knowledge, none of such persons has any direct or
indirect ownership interest in any firm or corporation with which the Company is
affiliated or with which the Company has a business relationship, or any firm or
corporation that competes with the Company, except that employees, officers,
directors or stockholders of the Company and members of their immediate families
may own stock in publicly traded companies that may compete with the Company.
No member of the immediate family of any officer or director of the Company is
directly or indirectly interested in any material contract with the Company
except as set forth in the Addendum.

     2.14 Permits.
          -------

     The Company has all franchises, permits, licenses, and any similar
authority necessary for the conduct of its business as now being conducted by
it, the lack of which could materially and adversely affect the business,
properties, prospects, or financial condition of the Company.  The Company is
not in default in any material respect under any of such franchises, permits,
licenses, or other similar authority.

                                      -6-
<PAGE>

     2.15 Environmental and Safety Laws. To its knowledge, the Company is not in
          -----------------------------
violation of any applicable statute, law or regulation relating to the
environment or occupational health and safety which could have a material
adverse effect on the Company, and to its knowledge, no material expenditures
are or will be required in order to comply with any such existing statute, law
or regulation

     2.16 Disclosure.
          ----------

     The Company has fully provided each Investor with all the information
pertaining to the Company that such Investor has requested for deciding whether
to purchase the Common Stock neither this Agreement, nor any other statements or
certificates made or delivered in connection herewith or therewith contains any
untrue statement of a material fact concerning the Company or omits to state a
material fact concerning the Company necessary to make the statements herein or
therein not misleading.

     2.17 Registration Rights.
          -------------------

     Except as provided in the Addendum, the Company has not granted or agreed
to grant any registration rights, including piggyback rights, to any person or
entity.

     2.18 Corporate Documents.
          -------------------

     The Amended Certificate and Bylaws of the Company are, or will be at the
Closing, in the form previously provided to special counsel for the Investors.

     2.19 Title to Property and Assets.
          ----------------------------

     The Company owns its property and assets free and clear of all mortgages,
liens, loans and encumbrances, except such encumbrances and liens that arise in
the ordinary course of business and do not materially impair the Company's
ownership or use of such property or assets.  With respect to the property and
assets it leases, the Company is in material compliance with such leases and, to
its knowledge, holds a valid leasehold interest free of any liens, claims or
encumbrances.

     2.20 Financial Statements.
          --------------------

     The Company has delivered to each Investor its audited financial statements
(balance sheet and statement of operations) as of and for the year ended
December 31, 1999 (the "Financial Statements").  The Financial Statements fairly
present the financial condition and operating results of the Company as of the
dates, and for the periods, indicated therein.  Except as set forth in the
Financial Statements, the Company has no material liabilities, contingent or
otherwise (individually or in the aggregate), other than (i) obligations and
liabilities incurred in the ordinary course of business subsequent to December
31, 1999 and (ii) obligations under contracts and commitments incurred in the
ordinary course of business and not required under generally accepted accounting
principles to be reflected in the Financial Statements, which, in both cases,
individually or in the aggregate, are not materially adverse to the financial
condition or operating results of the Company.

                                      -7-
<PAGE>

Except as disclosed in the Financial Statements, the Company is not a guarantor
or indemnitor of any indebtedness of any other person, firm or corporation.

     2.21 Changes.
          -------

     Since December 31, 1999, no event or condition of any type has materially
and adversely affected the business, properties, prospects or financial
condition of the Company.

     2.22 Tax Returns, Payments and Elections
          -----------------------------------.

     The Company has filed all tax returns and reports (including information
returns and reports) as required by law.  These returns and reports are true and
correct in all material respects.  The Company has paid all taxes and other
assessments due, except those contested by it in good faith that are listed in
the Schedule of Exceptions.  The provision for taxes of the Company as shown in
the Financial Statements is adequate for taxes due or accrued as of the date
thereof.  The Company has not elected pursuant to the Internal Revenue Code of
1986, as amended (the "Code"), to be treated after December 31, 1996 as a
Subchapter S corporation or a collapsible corporation pursuant to Section
1362(a) or Section 341(f) of the Code, nor has it made any other elections
pursuant to the Code (other than elections that relate solely to methods of
accounting, depreciation or amortization) that would have a material effect on
the Company, its financial condition, its business as presently conducted or
proposed to be conducted or any of its properties or material assets.

     2.23 Insurance.
          ---------

     The Company has in full force and effect fire and casualty insurance
policies, with extended coverage, in customary amounts (subject to reasonable
deductibles) and which the Company believes is sufficient for its business as
conducted and as currently proposed to be conducted.

     2.24 Minute Books.
          ------------

     The copy of the minute books of the Company provided to the Investors
contain minutes of all meetings of directors and stockholders since the time of
incorporation and reflect all transactions referred to in such minutes
accurately in all material respects.

     2.25 Employee Matters.
          ----------------

     The Company is not aware that any officer or key employee, or that any
group of key employees, currently intends to terminate their employment with the
Company.  Except to the extent provided by law, the employment of each officer
and employee of the Company is terminable at the will of the Company.

                                      -8-
<PAGE>

     2.26 Brokers.
          -------

     The Company has no contract, arrangement or understanding with any broker,
finder or similar agent with respect to the transactions contemplated by this
Agreement.  The Company may be obligated to pay an advisor fee, and the Company
hereby indemnifies the Investors as to such fee.

3.   Representations and Warranties of the Investors.
     -----------------------------------------------

     Each Investor hereby represents and warrants that:

     3.1  Authorization.
          -------------

     Such Investor has full power and authority to enter into this Agreement and
the Addendum, and each such agreement constitutes its valid and legally binding
obligation, enforceable in accordance with its terms except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of
general application affecting enforcement of creditors' rights generally, and
(ii) as limited by laws relating to the availability of specific performance,
injunctive relief, or other equitable remedies.

     3.2  Purchase Entirely for Own Account.
          ---------------------------------

     This Agreement is made with such Investor in reliance upon such Investor's
representation to the Company, which by such Investor's execution of this
Agreement such Investor hereby confirms, that, except as set forth herein, the
Common Stock to be received by such Investor will be acquired for investment for
such Investor's own account, not as a nominee or agent, and not with a view to
the resale or distribution of any part thereof, and that such Investor has no
present intention of selling, granting any participation in, or otherwise
distributing the same.  By executing this Agreement, such Investor further
represents that, except as set forth herein, such Investor does not have any
contract, undertaking, agreement or arrangement with any person to sell,
transfer or grant participations to such person or to any third person, with
respect to any of the Securities.

     3.3  Disclosure of Information.
          -------------------------

     Such Investor believes it has received all the information it considers
necessary or appropriate for deciding whether to purchase the Common Stock.
Such Investor further represents that it has had an opportunity to ask questions
and receive answers from the Company regarding the terms and conditions of the
offering of the Common Stock and the business, properties, prospects and
financial condition of the Company.  The foregoing, however, does not limit or
modify the representations and warranties of the Company in Section 2 of this
Agreement or the right of the Investors to rely thereon.

     3.4  Investment Experience.
          ---------------------

     Such Investor is experienced in evaluating and investing in private
placement transactions of securities of companies in a similar stage of
development and acknowledges that it is able to fend for

                                      -9-
<PAGE>

itself, can bear the economic risk of its investment, and has such knowledge and
experience in financial or business matters that it is capable of evaluating the
merits and risks of the investment in the Common Stock. If other than an
individual, Investor also represents it has not been organized for the purpose
of acquiring the Common Stock.

     3.5  Accredited Investor.
          -------------------

     Such Investor is an "accredited investor" within the meaning of paragraph
(a)(3), (7) or(8) Securities and Exchange Commission ("SEC") Rule 501 of
Regulation D, as presently in effect.

     3.6  Restricted Securities.
          ---------------------

     Such Investor understands that the Securities it is purchasing are
characterized as "restricted securities" under the federal securities laws
inasmuch as they are being acquired from the Company in a transaction not
involving a public offering and that under such laws and applicable regulations
such securities may be resold without registration under the Act only in certain
limited circumstances.  In this connection, such Investor represents that it is
familiar with SEC Rule 144, as presently in effect, and understands the resale
limitations imposed thereby and by the Act.

     3.7  Further Limitations on Disposition.
          ----------------------------------

     Without in any way limiting the representations set forth above, such
Investor further agrees not to make any disposition of all or any portion of the
Securities unless and until the transferee has agreed in writing for the benefit
of the Company to be bound by this Section 3 and the Investor Rights Agreement;
provided that this Section and such agreement will not be necessary if:

     (a)  There is then in effect a Registration Statement under the Act
covering such proposed disposition and such disposition is made in accordance
with such Registration Statement; or

     (b)  (i) Such Investor shall have notified the Company of the proposed
disposition and shall have furnished the Company with a detailed statement of
the circumstances surrounding the proposed disposition, and (ii) if reasonably
requested by the Company, such Investor shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company, that such
disposition will not require registration of such securities under the Act.

     (c)  Notwithstanding the provisions of Paragraphs (a) and (b) above, no
such registration statement or opinion of counsel shall be necessary for a
transfer by an Investor that is a partnership or trust to a partner a
beneficiary of such partnership or trust or a retired partner of such
partnership who retires after the date hereof, or to the estate of any such
partner or retired partner or the transfer by gift, will or intestate succession
of any partner a beneficiary to his or her spouse or to the siblings, lineal
descendants or ancestors of such partner a beneficiary or his or her spouse, if
the transferee agrees in writing to be subject to the terms hereof to the same
extent as if he or she were an original Investor hereunder.

                                      -10-
<PAGE>

     3.8  Legends.
          -------

     It is understood that the certificates evidencing the Securities may bear
one or all of the following legends:

          (a)  "THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES ACT. THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, ASSIGNED, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE
OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH
ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT."

          (b)  Any legend required by state securities laws or any other
applicable jurisdiction.

          (c)  Any legend required by the Investor Rights Agreement.

4.   Conditions of Investors' Obligations at Closing.
     -----------------------------------------------

     The obligations of each Investor under subsection 1.1(c) of this Agreement
are subject to the fulfillment on or before the Closing of each of the following
conditions, the waiver of which shall not be effective against any Investor who
does not consent thereto:

     4.1  Representations and Warranties.
          ------------------------------

     The representations and warranties of the Company contained in Section 2
shall be true in all material respects on and as of the Closing with the same
effect as though such representations and warranties had been made on and as of
the date of such Closing.

     4.2  Performance.
          -----------

     The Company shall have performed and complied in all material respects with
all agreements, obligations and conditions contained in this Agreement that are
required to be performed or complied with by it on or before the Closing.

     4.3  Compliance Certificate.
          ----------------------

     The President of the Company shall deliver to each Investor at the Closing
a certificate stating that the conditions specified in Sections 4.1 and 4.2 have
been fulfilled and stating that there shall have been no material adverse change
in the business, affairs, prospects, operations, properties, assets or condition
of the Company since the date of the Financial Statements.

                                      -11-
<PAGE>

     4.4  Qualifications.
          --------------

     All authorizations, approvals, or permits, if any, of any governmental
authority or regulatory body of the United States or of any state that are
required in connection with the lawful issuance and sale of the Securities
pursuant to this Agreement shall be duly obtained and effective as of the
Closing.

     4.5  Proceedings and Documents.
          -------------------------

     All corporate and other proceedings in connection with the transactions
contemplated at the Closing and all documents incident thereto shall be
reasonably satisfactory in form and substance to Investors' special counsel, and
they shall have received all such counterpart original and certified or other
copies of such documents as they may reasonably request.  This may include,
without limitation, good standing certificates and certification by the
Company's Secretary regarding the Company's Amended Certificate and Bylaws and
Board of Director and stockholder resolutions relating to this transaction.

     4.6  Investor Rights Agreement.
          -------------------------

     The Company, the Consenting Holders and each Investor shall have entered
into the Addendum in the form attached hereto as Exhibit C providing the
                                                 ---------
Investor with "piggyback" registration rights on parity with the existing
holders of registration rights.

5.   Conditions of the Company's Obligations at Closing.
     --------------------------------------------------

     The obligations of the Company to each Investor under this Agreement are
subject to the fulfillment on or before the Closing of each of the following
conditions by that Investor:

     5.1  Representations and Warranties.
          ------------------------------

     The representations and warranties of the Investors contained in Section 3
shall be true in all material respects on and as of the Closing with the same
effect as though such representations and warranties had been made on and as of
the Closing.

     5.2  Payment of Purchase Price.
          -------------------------

     Each Investor shall have delivered the purchase price specified in Section
1.1 (c).

     5.3  Qualifications.
          --------------

     All authorizations, approvals, or permits, if any, of any governmental
authority or regulatory body of the United States or of any state that are
required in connection with the lawful issuance and sale of the Securities
pursuant to this Agreement shall be duly obtained and effective as of the
Closing.

                                      -12-
<PAGE>

     5.4  Lockup.
          ------

     Each Investor shall have executed and delivered to the Company the form of
Lockup Agreement attached hereto as Exhibit D.
                                    ---------

6.   Post-Closing Covenants.
     ----------------------

     6.1  Use of Proceeds.
          ---------------

     The Company agrees to use the investment proceeds from each Investor for
working capital purposes or to otherwise finance the anticipated growth of the
Company.

7.   Miscellaneous.
     -------------

     7.1  Survival of Warranties.
          ----------------------

     The warranties, representations and covenants of the Company and Investors
contained in or made pursuant to this Agreement shall survive the execution and
delivery of this Agreement and the Closing for a period of one year and shall in
no way be affected by any investigation of the subject matter thereof made by or
on behalf of the Investors or the Company.

     7.2  Successors and Assigns.
          ----------------------

     Except as otherwise provided herein, the terms and conditions of this
Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties (including transferees of any Securities).
Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.

     7.3  Governing Law.
          -------------

     This Agreement shall be governed by and construed under the laws of the
State of Texas without giving effect to any choice of law or conflict of law
provision.

     7.4  Counterparts.
          ------------

     This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and
the same instrument.

     7.5  Titles and Subtitles.
          --------------------

     The titles and subtitles used in this Agreement are used for convenience
only and are not to be considered in construing or interpreting this Agreement.

                                      -13-
<PAGE>

     7.6  Notices.
          -------

     Unless otherwise provided, any notice required or permitted under this
Agreement shall be given in writing and shall be deemed effectively given if
received, upon receipt, and otherwise upon personal delivery to the party to be
notified, or upon deposit with the United States Post Office, by registered or
certified mail, postage prepaid and addressed to the party to be notified at the
address indicated for such party on the signature page hereof, or at such other
address as such party may designate by ten (10) days' advance written notice to
the other parties.

     7.7  Finder's Fee.
          ------------

     Each Investor agrees to indemnify and to hold harmless the Company from any
liability for any commission or compensation in the nature of a finders' fee
(and the costs and expenses of defending against such liability or asserted
liability) for which such Investor or any of its officers, partners, employees,
or representatives is responsible.

     The Company agrees to indemnify and hold harmless each Investor from any
liability for any commission or compensation in the nature of a finders' fee
(and the costs and expenses of defending against such liability or asserted
liability) for which the Company or any of its officers, employees or
representatives is responsible.

     7.8  Expenses.
          --------

     Irrespective of whether the Closing is effected, the parties shall pay all
costs and expenses that they incur with respect to the negotiation, execution,
delivery and performance of this Agreement. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement, the prevailing
party shall be entitled to reasonable attorney's fees, costs and necessary
disbursements in addition to any other relief to which such party may be
entitled.

     7.9  Amendments and Waivers.
          ----------------------

     Any term of this Agreement may be amended and the observance of any term of
this Agreement may be waived (either generally or in a particular instance and
either retroactively or prospectively), only with the written consent of the
Company and the holders of a two-thirds of the Common Stock issuable or issued
upon conversion of the Common Stock.  Any amendment or waiver effected in
accordance with this paragraph shall be binding upon each holder of any
securities purchased under this Agreement at the time outstanding (including
securities into which such securities are convertible), each future holder of
all such securities, and the Company.

     7.10 Severability.
          ------------

     If one or more provisions of this Agreement are held to be unenforceable
under applicable law, such provision shall be excluded from this Agreement and
the balance of the Agreement shall be interpreted as if such provision was so
excluded and shall be enforceable in accordance with its terms.

                                      -14-
<PAGE>

     7.11 Aggregation of Stock.
          --------------------

     All shares of the Common Stock held or acquired by affiliated entities or
persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement.

     7.12 Entire Agreement.
          ----------------

     This Agreement and the documents referred to herein constitute the entire
agreement among the parties and no party shall be liable or bound to any other
party in any manner by any warranties, representations, or covenants except as
specifically set forth herein or therein.

                  [Remainder of page intentionally left blank]

                                      -15-
<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written.

                              COMPANY:

                              CLEARCOMMERCE CORPORATION

                              By: /s/ MICHAEL S. GRAJEDA
                                  ---------------------------------------------
                                  Michael S. Grajeda, Chief Financial Officer

                  SIGNATURE PAGE TO CLEARCOMMERCE CORPORATION
                        COMMON STOCK PURCHASE AGREEMENT
<PAGE>

                              INVESTORS:

                              CARDSERVICE INTERNATIONAL, INC.,
                              a California corporation

                              By:     /s/ CAESAR BERGER
                                      ----------------------------------------
                              Name:   /s/ Caesar Berger
                                      ----------------------------------------
                              Title:  Senior Vice President
                                      ----------------------------------------

                              THE BURTZLOFF FAMILY TRUST

                              By:  /s/ CHARLES BURTZLOFF, TRUSTEE
                                   -------------------------------------------
                                    Charles Burtzloff, Trustee

                  SIGNATURE PAGE TO CLEARCOMMERCE CORPORATION
                        COMMON STOCK PURCHASE AGREEMENT
<PAGE>

                                   EXHIBIT A
                                   ---------

                             Schedule of Investors
                             ---------------------

                                  Number of Shares          Purchase Price
Investor                              Purchased                of Shares
--------                              ---------                ----------

Cardservice International, Inc.,          (1)                      (2)
A California corporation
Burtzloff Family Trust,
Charles Burtzloff-Trustee                 (1)                      (2)

(1)  The Investors shall purchase an aggregate number of shares of Common Stock
of the Company (the "Securities") equal to the lesser of (i) 10% of the total
number of shares of Common Stock to be sold by the Company in its initial firm
commitment underwriting pursuant to a registration statement filed with the
Securities and Exchange Commission resulting in gross proceeds of at least $10
million and with a per share price of at least $17.67 (the "Qualified IPO") or
(ii) that number of shares of Common Stock which can be purchased at the IPO
Price for a total of $6,000,000. The shares shall be allocated among the
Investors at the Closing in such manner as shall be determined by the Investors
in their discretion; provided, however, that the Investors hereby agree, subject
to the terms of this Agreement, to purchase all of the Securities.

(2)  The price per share of Common Stock of the Company in the Qualified IPO to
     the public (the "IPO Price").

To:  Cardservice International, Inc.
     26775 Malibu Hills Rd.
     Argoura Hills, CA 91301

Attn.: Donald Hedlund

With copies to:

     Burtzloff Family Trust
-----------------------------------
     c/o Charles Burtzloff
-----------------------------------
     Cardservice International
----------------------------------
     26775 Malibu Hills Rd.
-----------------------------------
     Argoura Hills, CA 91301
-----------------------------------

<PAGE>

                                   EXHIBIT B
                                   ---------

<PAGE>

                                   EXHIBIT C
                                   ---------

<PAGE>

                                   EXHIBIT D
                                   ---------ADDENDUM TO LICENSE AGREEMENT

     This Addendum to License Agreement (hereinafter "ADDENDUM"), entered into
as of this __ day of December, 1999, supplements the License Agreement
(hereinafter referred to as "AGREEMENT"), dated December 11, 1998, by and
between Med-Design Corporation (hereinafter referred to as "LICENSOR") and
Becton, Dickinson and Company (hereinafter referred to as "BECTON").

     WHEREAS, the parties desire to extend the term of the OPTION under the
AGREEMENT, and the parties desire to include further products under the
AGREEMENT in the OPTION;

     NOW, THEREFORE, for and in consideration of the premises and the mutual
promises, contained herein, and other good and valuable consideration, the
receipt and sufficiency is hereby acknowledged, it is agreed by and between the
parties hereto, as follows:

     1. In addition to the OPTION PRODUCTS set forth in the AGREEMENT, "OPTION
PRODUCTS" as defined in the Agreement shall include further products
(hereinafter "ADDITIONAL OPTION PRODUCTS"), as follows:

          (a) Safety Dental Injector for injecting medication from a pre-filled
     dental cartridge, using retractable needle technology, such as the devices
     in Appendix A;

          (b) Safety Blood Donor Needle using retractable needle technology and
     designed to operate with an expandable reservoir, such as the device in
     Appendix B;

          (c) Safety Arterial Blood Gas Syringe, fixed or staked needle,
     including ABG II Add-on using retractable needle technology, such as the
     device in Appendix C;

          (d) Safety Guidewire Introducer using retractable needle technology
     such as the device in Appendix D;

<PAGE>

ADDENDUM
PAGE 2

          (e) Safety Vial Injector for injecting medication from a pre-filled
     vial, using retractable needle technology, such as the device in Appendix
     E;

          (f) Safety Tuberculine Syringe for injecting up to 1.0 cc of fluid,
     using retractable needle technology;

          (g) Safety Insulin Syringe for injecting insulin, using retractable
     needle technology.

          (h) Safety Spinal Needle for use in delivering or withdrawing fluid
     from the cerebrospinal fluid of the spinal column, using retractable needle
     technology; and

          (i) Safety Epidural Needle for use with a through-the-needle catheter
     to be used in delivering anesthetics to the epidural space, using
     retractable needle technology.

     2. The term of the OPTION under Article IX, Section 1, of the AGREEMENT,
shall be extended for 45 days to January 26, 1999, for the five (5) OPTION
PRODUCTS identified in Article 1, Section 13, of the AGREEMENT. The parties will
negotiate in good faith and in a timely fashion for a license to such OPTION
PRODUCTS that BECTON notifies LICENSOR it desires to license.

     3. At BECTON's option, LICENSOR agrees to grant to BECTON an exclusive
worldwide license, to make, use, sell and sublicense any one or more of the
ADDITIONAL OPTION PRODUCTS whether patented or not, at terms and conditions to
be negotiated. BECTON's option under this Section will expire on March 10, 2000
unless BECTON notifies LICENSOR on or before that date that it is interested in
acquiring a license on specific of the ADDITIONAL OPTION PRODUCTS. The parties
upon BECTON sending such notice will negotiate in good faith and in a timely
fashion during the subsequent fourteen (14) days the terms and conditions of
such license with respect to the ADDITIONAL OPTION PRODUCTS set forth in such
notice. During such fourteen (14) day period the provisions of Section 6 of this
Addendum will apply to

<PAGE>

ADDENDUM
PAGE 3

the ADDITIONAL OPTION PRODUCTS set forth in the notice. LICENSOR will have no
further obligation to BECTON with respect to ADDITIONAL OPTION PRODUCTS after
March 10, 2000 other than as provided in the previous two sentences with respect
to ADDITIONAL OPTION PRODUCTS set forth in such notice. If no agreement is
reached during such 14 day period BECTON's option under this Addendum for the
ADDITIONAL OPTION PRODUCTS in the notice will expire. In the event BECTON
acquires a license in one or more of the ADDITIONAL OPTION PRODUCTS, the parties
will take such steps necessary, if any, to vest within BECTON ownership to
rights under U.S. Patent 4,900,307 with respect to such ADDITIONAL OPTION
PRODUCT. In the event BECTON does not acquire a license with respect to any one
or more of the ADDITIONAL OPTION PRODUCTS, the parties will take such steps
necessary, if any, to vest within LICENSOR a limited non-exclusive, paid-up
royalty free license to make, use and sell and license the non-elected
ADDITIONAL OPTION PRODUCTS under U.S. Patent 4,900,307. The parties may extend
the option granted hereunder by mutual agreement.

     4.LICENSOR agrees to disclose in writing to BECTON, before December 31,
1999, subject to the confidentiality conditions of Article XII, paragraph 7, of
the AGREEMENT, all material information, including, but not limited to patent
applications, specifications, designs and prototypes for the ADDITIONAL OPTION
PRODUCTS, not previously disclosed to BECTON for BECTON's consideration and to
promptly disclose to BECTON material information developed hereafter on the
ADDITIONAL OPTION PRODUCTS as the products are further developed by LICENSOR.

     5. BECTON shall pay LICENSOR a payment of One Million Five Hundred Thousand
Dollars ($1,500,000) (hereinafter the "Addendum Payment") within five (5) days
from the date of execution of this ADDENDUM. The Addendum Payment will be
applied to any non-refundable, up-front license fee under any license agreement
entered into between the parties relative to one or more of the OPTION PRODUCTS
or ADDITIONAL OPTION PRODUCTS. In the event the non-refundable licensing fees
under such licenses, if any, are less than the

<PAGE>

ADDENDUM
PAGE 4

Addendum Payment or no license agreement is entered into, BECTON will have the
right until December 31, 2002 to elect with respect to the balance, i.e. the
difference between the Addendum Payment and the licensing fees paid under any
license agreement entered into between the parties relative to one or more of
the OPTION PRODUCTS or ADDITIONAL OPTION PRODUCTS (hereinafter the "Balance
Amount"), the following:

          (a) to apply the Balance Amount toward any other up-front,
     non-refundable payment for a license agreement that BECTON and LICENSOR may
     enter into after the execution of this Addendum and prior to December 31,
     2002. or

          (b) to have it applied to any money owed to LICENSOR under any future
     manufacturing or development agreement between BECTON and LICENSOR at a
     rate of 50% of the amount owing to LICENSOR, provided however that,
     LICENSOR shall not be required to work under such manufacturing or
     development agreement below its costs and expenses, and provided still
     further that, if the one half (50%) ratio set forth above is not acceptable
     to LICENSOR during the negotiations for such manufacturing and development
     agreement, then the parties will seek to agree to another ratio based on
     reasonable commercial practices.

Becton may at any time after the expiration of the options described herein and
prior to December 31, 2002, elect either:

          (c) to receive a payment from LICENSOR of one-half of the then
     remaining Balance Amount, or

(d) to apply one half of the then remaining Balance Amount toward the purchase
of stock in LICENSOR at the then current market price or, alternatively, that
the Balance Amount be applied toward the purchase of stock in LICENSOR at a 100%
premium to the then current market price (that is, twice the then current market
price), provided however that, in no event will the purchase price of the stock
under this subparagraph be less than 30% below the closing price

<PAGE>

ADDENDUM
PAGE 5

of the stock on 12/10/99,

the remainder of the Addendum Payment will be retained by LICENSOR.

     6. LICENSOR agrees that for the 45 day extension period under paragraph 2
relative to the OPTION PRODUCTS under Article IX, LICENSOR will not negotiate to
license or sell the OPTION PRODUCTS to any third party, and for the 90 day
period relative to the ADDITIONAL OPTION PRODUCTS under paragraph 1 hereof,
LICENSOR will not negotiate to license or sell the ADDITIONAL OPTION PRODUCTS to
any third party.

     7.   (a) LICENSOR represents and warrants that it has the right to grant
the rights set forth in this Addendum and is able to enter into this Addendum
and become bound by the terms hereof.

          (b) LICENSOR represents and warrants that it knows of no patent and
     patent applications owned by a third party that would be infringed by
     making, using, offering for sale, sale or importing of one of the OPTION
     PRODUCTS.

          (c) LICENSOR represents and warrants that is has not received any
     notice whether written or oral, that the OPTION PRODUCTS infringe any
     patents or patent applications of a third party.

          (d) LICENSOR represents and warrants that it is under no obligation to
     any third party that would interfere with its representatives or
     obligations under this Addendum.

          (e) LICENSOR represents and warrants that it has complied in all
     material respects with its obligations under the first sentence of Article
     IX, Section 1.

     8. Other than as set forth above, the terms and conditions of the AGREEMENT
shall govern

<PAGE>

ADDENDUM
PAGE 6

the rights and duties of the parties.

     The parties, intending to be legally bound, indicate their agreement to the
foregoing at the places provided below.

The Med-Design Corporation             Becton, Dickinson and Company

By: _______________________            By: _________________________
    James M. Donegan                       Name:
    President                              Its:

Date: _____________________            Date: _______________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}]]